About Genostics
Genostics is a company based in Sydney (Australia) founded in 2010 by Joachim Fluhrer. It operates as a B2C. Genostics offers products and services including Personalized Cancer Testing and Cancer Treatment Monitoring. Genostics operates in a competitive market with competitors including Denali Therapeutics, PTC Therapeutics, Poseida Therapeutics, Castle Biosciences and Juno Therapeutics, among others.
- Headquarter Sydney, Australia
- Founders Joachim Fluhrer
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genostics
Genostics offers a comprehensive portfolio of products and services, including Personalized Cancer Testing and Cancer Treatment Monitoring.
Monitors cancer treatment effectiveness and tracks status for personalized health insights.
Provides real-time tracking of cancer status to support ongoing medical care.
Funding Insights of Genostics
Detailed funding history for Genostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genostics
Investment portfolio details for Genostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genostics
Detailed financials for Genostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genostics Comparisons
Peer comparison for Genostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genostics
Genostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, PTC Therapeutics, Poseida Therapeutics, Castle Biosciences and Juno Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Small molecule drugs for rare diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Bioinformatics platforms are provided for cancer treatment identification.
|
Detailed competitors of Genostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genostics
Complete news archive for Genostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genostics
Genostics was founded in 2010.
Genostics is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Joachim Fluhrer is the current CEO of Genostics. They have also founded this company.
Genostics focuses on personalized cancer testing, using advanced technology to monitor treatment effectiveness and track cancer status in real-time. It enables individuals to keep a close eye on their health through innovative diagnostic services. The company emphasizes accurate, timely insights into cancer progression, supporting better health outcomes without specifying locations or clients.
Genostics's top competitors include Juno Therapeutics, PTC Therapeutics and Personalis.
Genostics offers Personalized Cancer Testing and Cancer Treatment Monitoring.